Skip to content

Aerie Pharmaceuticals, Inc.: filings

Every Aerie Pharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 37 filings, each linked to its SEC index.

Filing record ends 2022-11-04

The latest filing in this captured record is a 10-Q filed 2022-11-04. No later filing is in the SEC companyfacts record captured on 2026-09-22. Aerie Pharmaceuticals, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2022-11-04fiscal Q3 2022441260001337553-22-000041
10-Q2022-08-05fiscal Q2 2022441220001337553-22-000033
10-Q2022-05-06fiscal Q1 202244920001337553-22-000024
10-K2022-02-25fiscal FY 2021501290001337553-22-000013
10-Q2021-11-05fiscal Q3 2021441260001337553-21-000012
10-Q2021-08-05fiscal Q2 2021441220001628280-21-015620
10-Q2021-05-06fiscal Q1 202140840001628280-21-009136
10-K2021-02-26fiscal FY 2020461330001628280-21-003345
10-Q2020-11-06fiscal Q3 2020401100001628280-20-015829
10-Q2020-08-07fiscal Q2 2020401060001628280-20-012056
10-Q2020-05-07fiscal Q1 202040840001628280-20-006934
10-K2020-02-24fiscal FY 2019461310001628280-20-002027
10-Q2019-11-07fiscal Q3 2019421130001628280-19-013540
10-Q2019-08-08fiscal Q2 2019411070001628280-19-010318
10-Q2019-05-08fiscal Q1 201940830001628280-19-006143
10-K2019-03-01fiscal FY 2018431230001628280-19-002369
10-Q2018-11-07fiscal Q3 201839980001628280-18-013882
10-Q2018-08-09fiscal Q2 201838960001628280-18-010840
10-Q2018-05-09fiscal Q1 201835720001628280-18-006291
10-K2018-03-01fiscal FY 2017371100001628280-18-002651
10-Q2017-11-09fiscal Q3 201733880001628280-17-011249
10-Q2017-08-03fiscal Q2 201733880001628280-17-008029
10-Q2017-05-03fiscal Q1 201732660001628280-17-004800
10-K2017-03-09fiscal FY 2016351080001628280-17-002421
10-Q2016-11-03fiscal Q3 201632860001628280-16-020708
10-Q2016-08-04fiscal Q2 201629800001628280-16-018445
10-Q2016-05-03fiscal Q1 201629600001628280-16-015353
10-K2016-03-02fiscal FY 201532990001628280-16-012101
10-Q2015-11-06fiscal Q3 201529800001628280-15-008472
10-Q2015-08-06fiscal Q2 201529800001628280-15-006174
10-Q2015-05-08fiscal Q1 201526540001628280-15-003920
10-K2015-02-27fiscal FY 201427840001628280-15-001188
10-Q2014-11-12fiscal Q3 201427770001193125-14-409460
10-Q2014-08-07fiscal Q2 201426760001193125-14-300850
10-Q2014-05-13fiscal Q1 201425580001193125-14-197055
10-K2014-03-26fiscal FY 2013261000001193125-14-116752
10-Q2013-12-05fiscal Q3 201327810001193125-13-463557

Inspect the source

Entity
Aerie Pharmaceuticals, Inc. / CIK 0001337553
Captured
SEC response SHA-256
a519d71e3be6a3d1cbc0ee1d189382c2f398daae9371b18794768152ed5e3732

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001337553.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))